Research Archive — Page 3 of 133
-
April 20, 2026
Drug lifts ‘brain fog’ from lupus patients: Clinical trial
An estimated 200,000 people in the United States have lupus. About 80% of them experience “brain fog,” cognitive problems that impair learning, memory and attention. -
April 18, 2026
Rapid bloodstream infection testing shows high potential for timely, lifesaving treatment: Study
Gram-negative bacteria bloodstream infections are a major cause of illness and death worldwide, especially where antimicrobial resistance is more common. -
April 17, 2026
C. diff study enrolling patients over 65 at increased risk of infection
Participants in the BEETHOVEN study will be randomized to receive two C. difficile vaccine doses six months apart, or a placebo, to learn if an investigational vaccine is safe and can help prevent C. difficile infection in people age 65 and older. -
April 10, 2026
Weekly buprenorphine injection proves more effective for pregnant women with opioid use disorder
Vanderbilt Health’s Firefly program continues to lead the way in caring for pregnant women with substance use disorder. -
April 8, 2026
Adding steps offsets risk of chronic disease: Study
Using Fitbits, researchers set out to discover how many additional steps patients need to reduce risks of chronic disease. -
April 7, 2026
AI finds drug safety signals in clinical notes
Large language models were tested on cancer patient notes from two academic medical centers and seven drug trials. -
April 7, 2026
Multi-institutional team pioneers retinal test for early Alzheimer’s disease
The potential for a retinal screening test was bolstered by a recent discovery that clearance of amyloid-beta oligomers by immune cells in retinal blood vessels was disrupted in donor eyes from individuals with Alzheimer’s disease, compared to age-matched, healthy control eyes.